Solvemed is a VC-backed Neuroscience AI company working to redefine neurology care and drug development.
Solvemed has raised €3.6M across 1 funding round from 8 investors, most recently a round in Oct 2022. Based in Cambridge, UK; active in Software. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-10 | Other | €3.6M |
| APEX Ventures,Atmos Ventures,Atomico Angels,Cambrige Angels,Preface Ventures,Sunfish Partners +2 more |
| View deal → |
